Tate & Lyle plc
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Anthony Nicholas Seymour Hampton
- Full Time Employees
- 4,840
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- 5 Marble Arch London LO United Kingdom W1H 7EJ
- IPO Date
- Jan 5, 2010
- Website
- tateandlyle.com
- Similar Companies
- Business
- Tate & Lyle plc is a global provider of food and beverage ingredients, specializing in specialty food ingredients and primary products derived from corn and other starches. The company offers texturants such as starches, gums, and pectin; sweeteners including allulose, maltitol, and trehalose; fortification solutions with vitamins, minerals, and probiotics; and plant-based solutions for meat alternatives and beverages; along with enzymes, fibers, and acidulants for applications in bakery, beverages, dairy, snacks, soups, sauces, and plant-based products. It operates primarily in the food and beverage industry, serving multinational manufacturers and brands with sustainable, science-backed solutions across North America, Europe, and international markets, with headquarters in London, UK, and a history dating back to its founding as a sugar refiner in 1921 following the merger of Henry Tate & Sons and Abram Lyle & Sons.[web:previous] In recent developments, Tate & Lyle completed the acquisition of CP Kelco in 2024, significantly expanding its texturants portfolio with leading pectin and xanthan gum brands to strengthen its position in clean-label and reduced-sugar formulations. The company also launched its DOLCIA Prima allulose production facility in the US in 2023, scaling up this low-calorie sweetener amid growing demand for sugar reduction; and formed a strategic partnership with dsm-firmenich in 2024 to develop next-generation premixes for fortified foods targeting emerging markets. These moves reflect ongoing strategic shifts toward specialty ingredients growth, divestment of commodity operations like sweeteners in 2023, and sustainability initiatives including net-zero ambitions by 2050.[web:previous]
Ingredion to Take Over Tate & Lyle in $3.6 Billion Deal
Tate & Lyle agrees £3.8bn takeover by US rival
Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle
UK's Tate & Lyle agrees $3.6 billion Ingredion takeover
Tate & Lyle plc (TATYY) Q4 2026 Earnings Call Transcript
Tate & Lyle H2 Earnings Call Highlights
Ingredion Takeover Target Tate & Lyle Posts Fall in Profit
BioHarvest Sciences and Tate & Lyle expand sweetener development program
Tate & Lyle is a sweet opportunity for bidders says broker
Tate & Lyle In Talks With Ingredion Over $3.7 billion Takeover Offer
Britain's Tate & Lyle in discussions with US rival Ingredion for $3.7 billion takeover bid
Tate & Lyle plc (TATYY) Q3 2026 Earnings Call Transcript
Tate & Lyle plc (TATYY) Q2 2026 Earnings Call Transcript
Tate & Lyle edges higher as CP Kelco integration builds momentum
Tate & Lyle has a lot on its plate ahead of interim results
How does Tate & Lyle plan to get back on track?
Tate & Lyle plc (TATYY) Q2 2026 Earnings Call Transcript
Tate & Lyle slides on profit warning due to 'slowdown in market demand'
Tate & Lyle Lowers Revenue, Earnings View on Slow Market Demand
Tate & Lyle gets sour taste from investment bank downgrade on Sucralose risks